Literature DB >> 2205651

Prevalence of anti-group B streptococcal type III capsular IgG antibodies in the United Kingdom and an analysis of their specific IgG subclasses.

R G Feldman1, A Ferrante.   

Abstract

Neonatal infection due to group B streptococcus (GBS) has a higher incidence in the USA than in the United Kingdom. A British population was investigated to ascertain the proportion of women who have protective anti-GBS type III IgG levels. Thirty-one (34%) of 90 pregnant women, 10 (43%) of 23 nonpregnant women, and 5 (50%) of 10 mothers of healthy colonized infants had anti-type III IgG greater than or equal to 2 micrograms/ml. Of 19 mothers who had infants infected with GBS type III, 17 (89%) had low specific IgG levels; of the other 2, the infants themselves had low IgG levels. The proportion of women in the UK with protective antibody levels is higher than in the USA. Sera (12) were assayed for anti-type III IgG isotypes; all contained IgG2, 6 had detectable IgG1, and 1 had IgG4.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205651     DOI: 10.1093/infdis/162.4.883

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Prevalence of group B streptococcal type VI capsular IgG antibodies in Japan.

Authors:  K Matsubara; K Katayama; K Baba; H Nigami; H Harigaya
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-24       Impact factor: 3.267

2.  Humoral immune responses of Solomon Islanders to the merozoite surface antigen 2 of Plasmodium falciparum show pronounced skewing towards antibodies of the immunoglobulin G3 subclass.

Authors:  C M Rzepczyk; K Hale; N Woodroffe; A Bobogare; P Csurhes; A Ishii; A Ferrante
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Seroprevalence of antibodies to group B streptococcal polysaccharides in Gambian mothers and their newborns.

Authors:  R O Suara; R A Adegbola; E K Mulholland; B M Greenwood; C J Baker
Journal:  J Natl Med Assoc       Date:  1998-02       Impact factor: 1.798

4.  Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils.

Authors:  L A Sanders; R G Feldman; M M Voorhorst-Ogink; M de Haas; G T Rijkers; P J Capel; B J Zegers; J G van de Winkel
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

5.  Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.

Authors:  T Lagergård; K Thiringer; L Wassén; R Schneerson; B Trollfors
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

6.  Immunoglobulin G subclass responses to mycobacterial lipoarabinomannan in HIV-infected and non-infected patients with tuberculosis.

Authors:  C T Da Costa; S Khanolkar-Young; A M Elliott; K M Wasunna; K P McAdam
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

Review 7.  Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.

Authors:  Miwako Kobayashi; Johan Vekemans; Carol J Baker; Adam J Ratner; Kirsty Le Doare; Stephanie J Schrag
Journal:  F1000Res       Date:  2016-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.